Antibody–Drug Conjugates as Targeted Degraders for Antitumor Therapy: MRG003 Induces Lysosomal EGFR Degradation to Overcome Resistance in NSCLC
M. Chang, , W. Wang*, J. Dai*, Q. Liu*M. Chang, Z. Dai, J. Wang, M. Yang, R. Wang, P. Dai, X. Deng, X. Liu, Y. Zhong, K. Zhang, W. Wang*, J. Dai*, Q. Liu*
M. Chang, , Y. Guo*, J. Dai*, Q. Liu*, W. Wang*M. Chang, K. Zhang, J. Wang, F. Bi, Z. Dai, M. Yang, M. Liu, H. Peng, F. Zhang, Y. Guo*, J. Dai*, Q. Liu*, W. Wang*
M. Chang, , W. Wang*M. Chang, F. Gao, G. Gnawali, H. Xu, Y. Dong, X. Meng, W. Li, Z. Wang, B. Lopez, J. S. Carew, S. T. Nawrocki, J. Lu, Q.-Y. Zhang, W. Wang*
F. Lou, C. Li, , Z.-X. Yu*, W. Wang*, S.-L. Zhang*F. Lou, C. Li, J. Peng, Y. Zhou, J. Gui, L. Chen, Y. Yin, X. Zhang, Y. Hu, X. Chen, X. Liu, X. Chen, Z.-X. Yu*, W. Wang*, S.-L. Zhang*